How are advanced diagnostics benefitting patients? Our recent webinar discussed next-gen molecular analysis in precision ...

New York University researchers say a simple, gene-based blood test has shown to be highly accurate in predicting whether ...

Researchers used digital polymerase chain reaction assays to measure BRAF V600E or BRAF V600K circulating tumor DNA in ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study ...

Study findings suggested that assessing ctDNA levels was as good or better at predicting recurrence than experimental tests that examine a tumor itself.

This tumor DNA, also known as circulating tumor DNA (ctDNA), is released by cancer cells into the bloodstream. Tracking ctDNA ...

CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the ...

A research team led by Prof. Gu Hongcang from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has ...

The addition of serial circulating tumor DNA assays to imaging surveillance offered little benefit to patients with stage II to stage IV colorectal cancer who underwent curative-intent resection, ...

Outpatient administration of CAR T-cell therapies can reduce costs and improve patient satisfaction, with evolving ...

C, provided insights on what to consider when treating patients with HR+, HER2- breast cancer in the second line of treatment ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.